600 SU/ml, 1600 SU/ml, 4000 SU/ml – basic treatment
4000 SU/ml – maintenance treatment
suspension for injection
Mixture of allergoids from 13 grass pollen
POLLINEX + Rye is a medicine that contains a mixture of modified extracts (allergoids)
from the pollen of 13 commonly encountered grasses.
POLLINEX + Rye is used to treat allergic rhinitis, allergic conjunctivitis
and mild or moderate allergic asthma, caused by grass pollen, in adults,
adolescents and children over 6 years old.
In the case of allergic rhinitis, the presence of pollen causes sneezing, a stuffy nose, runny nose and
burning and tearing of the eyes. The modified grass pollen extracts (allergoids) in POLLINEX + Rye are released gradually, which reduces the risk of side effects.
Tell your doctor if you have any heart or lung disease. This does not exclude the use of POLLINEX + Rye, but the decision to use the medicine will be made by your doctor.
As far as possible, avoid exposure to grass pollen.
Tell your doctor or pharmacist about the use of the following medicines before using POLLINEX + Rye:
Tell your doctor about all the medicines you are taking now or have taken recently, and about the medicines you plan to take.
Do not eat a heavy meal or drink alcohol immediately before the planned injection of the medicine.
Pregnant women should not start using POLLINEX + Rye. If a woman becomes pregnant during treatment, therapy can be continued after a thorough assessment of her overall health and reaction to previous doses of the medicine.
There is no data on the penetration of POLLINEX + Rye into breast milk.
This medicine may occasionally cause mild drowsiness. If this occurs, do not drive or operate machinery.
POLLINEX + Rye contains less than 1 mmol (23 mg) of sodium per dose, which means it is "sodium-free".
This medicine should not be used during the grass pollen season.
Therapy with POLLINEX + Rye should be carried out by a specialist allergist in a clinic equipped with an emergency kit.
POLLINEX + Rye should be injected subcutaneously with constant pressure on the syringe plunger.
POLLINEX + Rye should not be used in children under 6 years of age.
POLLINEX + Rye basic treatment | Three doses of 0.5 ml with increasing concentrations: 300, 800, and then 2000 SU* should be injected with an interval of 7-14 days |
Maintenance treatment (can be used after basic treatment) | Three doses of 0.5 ml with a concentration of 2000 SU* should be injected with an interval of 1-6 weeks |
*SU - standardized units
Tell your doctor if the interval between injections of POLLINEX + Rye is longer than 14 days in the case of basic treatment or longer than 6 weeksin the case of maintenance treatment, as it may be necessary to reduce the dose or restart treatment.
It is recommended that POLLINEX + Rye treatment be continued for three to five years.
The patient should remain under medical supervision for at least 30 minutesafter each injection,
as they may require treatment if an allergic reaction occurs or until the symptoms of the reaction subside.
Do not rub the injection site.
Do not engage in intense physical activity within 12 hours before and after the injection.
If the patient has scheduled other preventive vaccinations against bacteria or viruses (e.g. flu vaccination), it is necessary to allow an interval of at least one week
between the injection of POLLINEX + Rye and another vaccine.
The next doseof POLLINEX + Rye can be injected after two weeks from another vaccination, provided that all symptoms related to any side effects caused by the previous vaccination have completely subsided.
The medicine will be injected by a doctor or nurse, so it is unlikely that an incorrect dose will be administered. Tell your doctor about any doubts related to the dose of the medicine.
Follow the schedule for injecting POLLINEX + Rye. If the interval between doses exceeds 14 days in the case of basic treatment or 6 weeks in the case of maintenance treatment, tell your doctor or nurse, as it may be necessary to reduce the dose.
If the use of POLLINEX + Rye is stopped without consulting a doctor, the symptoms of the disease may worsen.
If you have any further doubts about the use of this medicine, consult your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Anaphylactic shock may occur within a few minutes after injection of this medicine, often before the onset of a reaction at the injection site.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,
Al.Jerozolimskie181C, 02-222 Warsaw, Tel.: + 48 22 49 21 301, Fax: + 48 22 49 21 309, e-mail:
ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
POLLINEX + Rye is a white, turbid suspension for injection.
The medicine is available in two kits:
3 vials of 1.0 ml suspension:
Vial No. 1 (green) 600 SU/ml
Vial No. 2 (yellow) 1600 SU/ml
Vial No. 3 (red) 4000 SU/ml
5 single-use syringes and 5 single-use needles
1 vial of 1.5 ml suspension:
Vial No. 3 (red) 4000 SU/ml
3 single-use syringes and 3 single-use needles
Allergy Therapeutics (UK) Limited
Dominion Way
Worthing
West Sussex
BN14 8SA
United Kingdom
Allergy Therapeutics Ibérica, S.L.U.;
Avenida de Barcelona 115, Edificio Brasol, 2 planta
--------------------------------------------------------------------------------------------------------------------------------
Ref. No.:
Patient:
Date of birth:
Basic treatment:doses should be injected at intervals of 7 to a maximum of 14 days.
Vial No. | Recommended dose in ml (SU) | Alternative dose* in ml | Dose administered in ml | Date | Comments |
1 green | 0.5 (300) | 0.2 | |||
0.5 | |||||
2 yellow | 0.5 (800) | 0.2 | |||
0.5 | |||||
3 red | 0.5 (2000) | 0.2 | |||
0.5 |
*alternative dose for highly sensitized patients
Maintenance treatment:doses should be injected at intervals of 1-4 weeks (up to 6 weeks).
Recommended dose in ml (SU) | Dose administered in ml | Date | Comments |
0.5 (2000) | |||
0.5 (2000) | |||
0.5 (2000) | |||
0.5 (2000) | |||
0.5 (2000) | |||
0.5 (2000) | |||
0.5 (2000) | |||
0.5 (2000) |
If the recommended interval between injections is exceeded, the dose should be modified as follows:
Basic treatment
Exceeding the interval | Modification |
Break longer than 2-4 weeks | Do not increase the dose, repeat the previous dose |
Break longer than 4 weeks | For safety reasons, start treatment with the smallest dose |
Maintenance treatment
Exceeding the interval | Modification |
Break longer than 6 weeks | For safety reasons, start treatment with the smallest dose |
Reaction | Modification |
Swelling at the injection site with a diameter of 5-10 cm Swelling at the injection site with a diameter > 10 cm Systemic reaction of mild to moderate severity Severe systemic reaction, anaphylactic shock | Do not increase the dose, repeat the last dose Go back 1 step in the dosing schedule Go back 2 steps in the dosing schedule Verify the indications for treatment and assess the benefit-risk ratio |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.